Mitsubishi UFJ Kokusai Asset Management Co. Ltd. cut its holdings in shares of Stericycle, Inc. (NASDAQ:SRCL) by 37.9% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 16,360 shares of the business services provider’s stock after selling 9,986 shares during the quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in Stericycle were worth $1,172,000 as of its most recent SEC filing.
Several other hedge funds have also bought and sold shares of the stock. ST Germain D J Co. Inc. increased its holdings in shares of Stericycle by 0.8% during the 3rd quarter. ST Germain D J Co. Inc. now owns 133,598 shares of the business services provider’s stock worth $9,568,000 after acquiring an additional 1,090 shares during the last quarter. First Merchants Corp acquired a new position in shares of Stericycle during the 3rd quarter worth approximately $1,483,000. Wedge Capital Management L L P NC increased its holdings in shares of Stericycle by 16.2% during the 3rd quarter. Wedge Capital Management L L P NC now owns 554,881 shares of the business services provider’s stock worth $39,741,000 after acquiring an additional 77,347 shares during the last quarter. Andra AP fonden increased its holdings in shares of Stericycle by 46.1% during the 3rd quarter. Andra AP fonden now owns 22,200 shares of the business services provider’s stock worth $1,590,000 after acquiring an additional 7,000 shares during the last quarter. Finally, Goelzer Investment Management Inc. increased its holdings in shares of Stericycle by 8.0% during the 3rd quarter. Goelzer Investment Management Inc. now owns 56,568 shares of the business services provider’s stock worth $4,051,000 after acquiring an additional 4,213 shares during the last quarter. 94.19% of the stock is currently owned by institutional investors and hedge funds.
In other news, Director Mark C. Miller sold 19,753 shares of the company’s stock in a transaction on Monday, October 30th. The stock was sold at an average price of $70.52, for a total transaction of $1,392,981.56. Following the completion of the sale, the director now directly owns 205,576 shares in the company, valued at approximately $14,497,219.52. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 3.30% of the company’s stock.
A number of research firms recently weighed in on SRCL. Barrington Research decreased their target price on Stericycle from $87.00 to $75.00 and set an “outperform” rating on the stock in a report on Friday. BMO Capital Markets decreased their price objective on Stericycle from $74.00 to $62.00 and set a “market perform” rating on the stock in a report on Friday. Stifel Nicolaus reaffirmed a “buy” rating and issued a $85.00 price objective (down from $95.00) on shares of Stericycle in a report on Thursday, November 9th. Royal Bank Of Canada decreased their price objective on Stericycle from $74.00 to $67.00 and set an “underperform” rating on the stock in a report on Thursday, November 9th. Finally, Jefferies Group LLC set a $108.00 price objective on Stericycle and gave the company a “buy” rating in a report on Tuesday, October 17th. Four analysts have rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and an average target price of $77.17.
Shares of Stericycle, Inc. (NASDAQ:SRCL) opened at $64.06 on Tuesday. The firm has a market capitalization of $5,465.57, a price-to-earnings ratio of 14.75, a PEG ratio of 1.75 and a beta of 0.19. The company has a current ratio of 0.82, a quick ratio of 0.82 and a debt-to-equity ratio of 0.93. Stericycle, Inc. has a 1 year low of $61.62 and a 1 year high of $88.00.
Stericycle (NASDAQ:SRCL) last released its earnings results on Wednesday, November 8th. The business services provider reported $1.10 earnings per share for the quarter, missing analysts’ consensus estimates of $1.14 by ($0.04). The company had revenue of $883.00 million for the quarter, compared to the consensus estimate of $896.81 million. Stericycle had a negative net margin of 0.79% and a positive return on equity of 13.93%. The business’s revenue was down .8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.24 earnings per share. sell-side analysts anticipate that Stericycle, Inc. will post 4.49 earnings per share for the current year.
Stericycle Company Profile
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.